In spite of the introduction of the anti-vascular endothelial growth factor (VEGF) therapy, which can slow the progression of exudative AMD, the therapeutic options for AMD are far from satisfactory [19]. The gene discussed is VEGFA; the disease is age-related macular degeneration.